|
|
|
| home > ict > Spring 2017 |
|
|
 PUBLICATIONS |
International Clinical Trials |
|
|
|
|
|
 |
| |
|
|
|
|
End Point
Getting Better
Dr Graham Hughes looks for real change across the last 20 years of the pharma industry and proposes that the sector needs to start thinking outside the box in order to evolve.
|
|
|
|
|
eCRF and GDPR Compliance
Rules and Regulations
Those running clinical trials will have another set of regulations to keep in mind come May 2018, as the GDPR on data protection comes into effect across the EU. Christer Nilsson at Trial Online deciphers what action is needed to handle the impact on businesses, trials and software.
|
|
|
Standardised CTMS
Strength through Collaboration
James Batchelor at the University of Southampton promotes research teams coordinating both nationally and internationally, in safely changing routine standards of clinical care to improve patient quality of life.
|
|
|
TMF Survey
Built with Purpose
Rik van Mol at Veeva Systems considers the benefits of going digital, from cost savings to enabling faster study start-ups, as CROs blaze the trail of moving from paper to electronic trial master file applications.
|
|
|
|
Rare Disease Trials
Odd One Out
The very nature of rare diseases means they pose an intimidating challenge for those creating pharmaceutical development programmes. Jeffrey Zucker at Worldwide Clinical Trials faces down the aspects of such studies that make it so difficult to recruit and retain participants.
|
|
|
|
|
Data Management & Pharmacovigilance
On the Lake
Sudeep Pattnaik at ThoughtSphere tackles the growing complexity of trials with the help of data lakes. These storage repositories facilitate cross-examination across different systems, offering great benefits for those who safely collect and analyse their results regardless of the source.
|
|
|
Platform as a Service
Data on Trial
Steve Canham at Canham Information Systems and Will Crocombe at RISG Consulting argue that increased transparency is key to improving PaaS infrastructure in clinical research, and review what steps providers and consumers will need to take for external hosting provision of trial data.
|
|
|
|
|
Translating Medical Terminology
Language Barriers
Misinterpretations can be hazardous to patients. Jack Cater at Corporate Translations lays out the options for medical translators faced with unknown terminology or words with no direct analogue.
|
|
|
|
|
Patient Enrolment
Needle in a Haystack
Small patient population and medical uncertainties make it difficult to recruit participants for rare disease trials. Dr Scott Treiber at Chiltern reveals how conducting such studies can offer many unique advantages.
|
|
|
Recruitment Strategies for Dermatology Trials
Reaching Out
Darcee Duke Strube and Milena Reckseit at Novella Clinical explain how online marketing methods are useful when recruiting patients for dermatology trials, as the traditional methods for attracting an audience are eclipsed by the digital era.
|
|
|
Globalisation and Patient-Centric Language
Turn of Phrase
Communication is key to boosting retention rates and improving ties between researchers and participants. As more and more clinical trials are being outsourced to countries with different cultures and languages, Alicia Lewis at MD Group highlights the importance of competent translation.
|
|
|
|
|
Q&A: Linguistic Challenges
Word for Word
In this question and answer feature, SeproTec Multilingual Solutions’ Juan Julián León tells ICT about the qualities needed for excellence in pharmaceutical translation, as well as the innovations and challenges facing his specialised field.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Huge boom in Korean Pharma reported at CPhI Korea
Amsterdam, 19th September 2019: The recently-closed CPhI Korea – co-organised by Informa Markets and the Korea Pharmaceutical Traders
Association (KPTA) – has seen a surge in growth across domestic and
international pharma companies, as well as a sizable rise in overall
attendees. As reported earlier this year in the provisional findings of
the CPhI Pharma Index[1], Korea has seen a rapid growth in its
international reputation (seeing its ‘overall competitiveness’ rise 14%
in the last two years), which is now translating into a sizable growth
in the market and at the event.
More info >> |
|
 |
White Papers |
 |
|
Accelerate Your Database Lock Using Clean Patient Optics
Bioclinica
Because a key step towards database lock is obtaining clean data for all patients, the ability to verify that data are clean early accelerates the ability to lock the clinical database. This ultimately shortens the overall study timeline while ensuring the quality of your data. However, this can be challenging when manually reviewing study data, particularly with larger studies.
More info >> |
|
 |
Industry Events |
 |
2020 Avoca Quality and Innovation Summit
3-4 June 2020, Amsterdam, The Netherlands
The 2020 Avoca Quality and Innovation Summit will take place 3-4 June
2020, in Amsterdam, The Netherlands.
More info >> |
|
|
